BVS
Price
$7.02
Change
+$0.17 (+2.48%)
Updated
Jul 3 closing price
Capitalization
330.84M
39 days until earnings call
WUXAY
Price
$10.24
Change
+$0.24 (+2.40%)
Updated
Jul 3 closing price
Capitalization
31.13B
Interact to see
Advertisement

BVS vs WUXAY

Header iconBVS vs WUXAY Comparison
Open Charts BVS vs WUXAYBanner chart's image
Bioventus
Price$7.02
Change+$0.17 (+2.48%)
Volume$172.47K
Capitalization330.84M
Wuxi Apptec
Price$10.24
Change+$0.24 (+2.40%)
Volume$255
Capitalization31.13B
BVS vs WUXAY Comparison Chart in %
Loading...
BVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WUXAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BVS vs. WUXAY commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVS is a Hold and WUXAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (BVS: $7.02 vs. WUXAY: $10.24)
Brand notoriety: BVS and WUXAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BVS: 37% vs. WUXAY: 4%
Market capitalization -- BVS: $330.84M vs. WUXAY: $31.13B
BVS [@Medical Specialties] is valued at $330.84M. WUXAY’s [@Medical Specialties] market capitalization is $31.13B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVS’s FA Score shows that 0 FA rating(s) are green whileWUXAY’s FA Score has 2 green FA rating(s).

  • BVS’s FA Score: 0 green, 5 red.
  • WUXAY’s FA Score: 2 green, 3 red.
According to our system of comparison, WUXAY is a better buy in the long-term than BVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVS’s TA Score shows that 3 TA indicator(s) are bullish while WUXAY’s TA Score has 2 bullish TA indicator(s).

  • BVS’s TA Score: 3 bullish, 3 bearish.
  • WUXAY’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, BVS is a better buy in the short-term than WUXAY.

Price Growth

BVS (@Medical Specialties) experienced а +5.41% price change this week, while WUXAY (@Medical Specialties) price change was +4.49% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

BVS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WUXAY($31.1B) has a higher market cap than BVS($331M). WUXAY has higher P/E ratio than BVS: WUXAY (22.94) vs BVS (10.66). WUXAY YTD gains are higher at: 49.155 vs. BVS (-33.143). WUXAY has higher annual earnings (EBITDA): 11.4B vs. BVS (-23.07M). WUXAY has higher revenues than BVS: WUXAY (39.8B) vs BVS (512M).
BVSWUXAYBVS / WUXAY
Capitalization331M31.1B1%
EBITDA-23.07M11.4B-0%
Gain YTD-33.14349.155-67%
P/E Ratio10.6622.9446%
Revenue512M39.8B1%
Total Cash37MN/A-
Total Debt395MN/A-
TECHNICAL ANALYSIS
Technical Analysis
BVSWUXAY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 3 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
BVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WUXAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTRE5.220.05
+0.97%
Fortrea Holdings
BMRN57.500.33
+0.58%
BioMarin Pharmaceutical
WLYB44.16N/A
N/A
John Wiley & Sons
PRFX1.40N/A
N/A
PainReform Ltd
EXOZ9.91-0.29
-2.84%
eXoZymes Inc

BVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BVS has been loosely correlated with OFIX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BVS jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVS
1D Price
Change %
BVS100%
+2.48%
OFIX - BVS
53%
Loosely correlated
+0.54%
TCMD - BVS
41%
Loosely correlated
N/A
CSTL - BVS
36%
Loosely correlated
+1.45%
RDNT - BVS
35%
Loosely correlated
+0.99%
MMSI - BVS
35%
Loosely correlated
+0.07%
More

WUXAY and

Correlation & Price change

A.I.dvisor tells us that WUXAY and QDEL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WUXAY and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WUXAY
1D Price
Change %
WUXAY100%
+2.40%
QDEL - WUXAY
22%
Poorly correlated
+0.03%
MOVE - WUXAY
9%
Poorly correlated
-1.33%
LNSR - WUXAY
4%
Poorly correlated
+0.53%
BVS - WUXAY
3%
Poorly correlated
+2.48%
KSRBF - WUXAY
3%
Poorly correlated
N/A
More